title: Platelet high-density lipoprotein activates transferrin-derived phagocytosis activators, MAPPs, following thrombin digestion.
abstract: Macromolecular activators of phagocytosis from platelets (MAPPs), transferrin-derived phagocytosis activators released from platelets, activate leukocytic phagocytosis via Fcγ receptors. It has been found that MAPPs can be prepared using stored platelets or their lysate. Using this artificial MAPP production system, it has been found that they can be produced from precursors (tetrameric and dimeric transferrins) following reaction with a low-molecular-weight (LMW) activator of MAPPs, which is liberated from a high-molecular-weight activator of MAPP (HMW activator) by reaction with thrombin. In this study, the HMW activator in platelet lysate was characterized by assaying phagocytosis of washed neutrophils. In an ultracentrifugation study of the platelet lysate, HMW activator activity was observed in the fraction corresponding to the density of high-density lipoprotein (HDL). The activity was observed in the apolipoproteins obtained from the HDL fraction. Among the apolipoproteins tested only apolipoprotein CIII showed the activity to produce MAPP in vitro. Affinity chromatography of the apolipoproteins from the HDL fraction of the platelet lysate using an anti-apolipoprotein CIII column revealed that the substance that binds with the antibody showed MAPP-forming activity. In a gel filtration study of thrombin-treated apolipoprotein CIII, a peak of LMW activator activity was observed for fractions with a molecular size smaller than that of apolipoprotein CIII. Finally, MAPP-forming activity of HDL obtained from the plasma was examined. MAPP was formed only when delipidized HDL was used. In conclusion, it is suggested that platelet HDL is the HMW activator and that this activation is achieved via apolipoprotein CIII after thrombin reaction in platelets.
authors.affiliation: Inflammation Pathology, Department of Pathology and Host Defense, Faculty of Medicine, Kagawa University, Kagawa, 761-0793, Japan. profsaka@med.kagawa-u.ac.jp
authors.forename: Haruhiko
authors.initials: H
authors.lastname: Sakamoto
authors.forename: Bin
authors.initials: B
authors.lastname: Wu
authors.forename: Yumiko
authors.initials: Y
authors.lastname: Nagai
authors.forename: Sumiko
authors.initials: S
authors.lastname: Tanaka
authors.forename: Masayuki
authors.initials: M
authors.lastname: Onodera
authors.forename: Takafumi
authors.initials: T
authors.lastname: Ogawa
authors.forename: Masaki
authors.initials: M
authors.lastname: Ueno
mesh_terms: D000818:Animals; D053305:Apolipoprotein C-III / Q000378:metabolism*; D001792:Blood Platelets / Q000737:chemistry* / Q000378:metabolism; D002457:Cell Extracts / Q000737:chemistry*; D002458:Cell Fractionation; D002499:Centrifugation, Density Gradient; D002846:Chromatography, Affinity; D002850:Chromatography, Gel; D004912:Erythrocytes / Q000166:cytology; D006801:Humans; D008075:Lipoproteins, HDL / Q000737:chemistry / Q000378:metabolism* / Q000494:pharmacology; D018375:Neutrophil Activation / Q000187:drug effects; D009504:Neutrophils / Q000166:cytology / Q000187:drug effects* / Q000378:metabolism; D010587:Phagocytosis / Q000187:drug effects; D012756:Sheep; D013917:Thrombin / Q000378:metabolism / Q000494:pharmacology*; D014168:Transferrin / Q000737:chemistry / Q000378:metabolism / Q000494:pharmacology*
chemical_list: D053305:Apolipoprotein C-III; D002457:Cell Extracts; D008075:Lipoproteins, HDL; D014168:Transferrin; D013917:Thrombin